Reviewed by Christian Espinosa, MBA, CISSP · Founder & CEO
Published December 2025 · Last reviewed May 2026
The Med Device Cyber Podcast · with Jim Goodmiller · December 30, 2025 In this episode of The Med Device Cyber Podcast, host Christian Torres and Trevor sat down with Jim Goodmiller from Bio Bridges to discuss the critical intersection of cybersecurity with regulatory and quality success in the medical device industry. Jim Goodmiller, with a unique background blending IT and life sciences, shared insights from his 30 years in consulting, emphasizing Bio Bridges' mission to guide companies from concept to commercialization.The conversation delved into the evolving landscape of medical device cybersecurity, highlighting the FDA's increasing scrutiny and the transition from vague guidelines to clear mandates for cybersecurity plans. They addressed the challenges faced by innovators and CEOs who often prioritize reimbursement and clinical trials over cybersecurity, leading to significant delays and costs if not addressed early. The discussion covered the pitfalls of neglecting cybersecurity in the product development roadmap, the impossibility of achieving perfect security, and the need for continuous iterative testing, such as penetration testing, throughout the device lifecycle. The episode also touched upon the complexities of managing cybersecurity for legacy devices in hospitals and the impact of recent high-profile cases, like the Illumina lawsuit and ransomware attacks, on industry awareness and regulatory enforcement. This episode is a must-listen for product security teams, regulatory leads, and engineers navigating the intricate world of medical device development.
Key Takeaways
- Cybersecurity must be integrated into medical device development from the concept phase, not as an afterthought, to avoid costly delays and regulatory setbacks.
- The FDA is increasingly stringent, requiring clear cybersecurity plans and roadmaps for product commercialization.
- Achieving perfect security in medical devices is unrealistic; manufacturers should expect and plan for vulnerabilities, addressing them through continuous, iterative testing.
- Legacy medical devices pose significant cybersecurity challenges, requiring a focused, incremental approach to bring them to modern standards.
- High-profile incidents such as the Illumina lawsuit and ransomware attacks underscore the severe consequences of cybersecurity negligence, including financial penalties and patient harm.
Listen on mdcpodcast.com · Watch on YouTube
Listen to this episode
Want help applying this to your own device program?
Blue Goat Cyber is a specialist medical device cybersecurity firm: 250+ FDA submissions, zero rejections. If anything in this conversation hit close to home, book a 30-minute strategy session - no cost, no obligation.